MedTrace Logo

CD Patients Immune Status Evaluation

NCT04135482 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2023-02-21

No results posted yet for this study

Summary

Using single cell sequencing method to evaluate and compare the immune status of patients with severe CD.

Conditions

  • Severe Crohn's Diease

Interventions

OTHER

colonic tissue biopsy

colonic tissue biospy of patients with severe crohn's disease using colonoscopy

Sponsors & Collaborators

  • First Affiliated Hospital of Zhejiang University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-21
Primary Completion
2020-07-15
Completion
2020-07-31

Countries

  • China

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04135482 on ClinicalTrials.gov